Leukemia and lymphoma. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Leukemia and lymphoma.

Leukemia and Lymphoma, Pathogenesis and Treatment, Molecular Aspects. 18th Symposium of the International Association for Competitive Research on Leukemia and Related Diseases. Kyoto, Japan, October 29 to November 3, 1995.. Unique Identifier : AIDSLINE MED/97618842
Anonymous; No affiliation given


Abstract: The XVIII Symposium of the International Association for Comparative Research on Leukemia and Related Diseases, Leukemia and Lymphoma/Pathogenesis and Treatment/Molecular Aspects, was held October 29-November 3, 1995 in Kyoto, Japan. The symposium included plenary sessions on gene rearrangement and leukemogenesis, progress in HTLV research, cytokine regulation, and apoptotic signals: gene therapy targets. Symposia topics were molecular leukemogenesis update; tumor suppressor genes in leukemogenesis; HIV and related virus pathogenesis; comparative retroviral leukemogenesis; retroviral pathogenesis; viral pathogenesis in animal models; hematopoiesis and leukemias; clinical studies in CML; and new therapeutic methods against leukemias and retroviral diseases. Updating Symposia topics were retroviruses and leukemia development; suppression of HIV replication; cell cycle regulation; cyclin inhibitors; retinoid biology; erythroid transcription factor; immuno-gene therapy; and HTLV-associated diseases. Eight minisymposia on progress in HTLV-1 research, oncogenic apoptotic genes, progress in HIV research, clinical aspects of leukemia, comparative leukemogenesis, hematopoietic regulation, gene rearrangement in leukemia, and cytokine signaling were also held. The symposium also included an opening ceremony, a panel discussion, a memorial lectureship, luncheon lectures, and poster sessions. Three Satellite Symposia were entitled: The Workshop on Roles of Transcriptional Regulator, Runt/AML1/PEBP2/CBF in Development, Differentiation, and Carcinogenesis; GIBCO-BRL Symposium on Virion-Cell Membrane Interaction Basis for Gene Transfer and Entry Block; and Leukemia Society of America/Chugai Research Institute of Molecular Medicine Joint Symposium on Immune System and Lymphomagenesis.
Keywords: *Leukemia/PATHOLOGY *Lymphoma/PATHOLOGYKWDleukemia/pathologyKWDlymphoma/pathology
971030
M97A1344

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .